Calithera Biosciences (CALA) Key Ratios

$0.00

up-down-arrow $-0.03 (-99.04%)

As on 02-Sep-2026 16:00EDT

Market cap

info icon

$0 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 22.88 89.38 63.53 15.66 -9.99
Net Profit 29.24 94.22 87.73 21.04 4.87
EPS 29.28 95.55 88.38 23.17 11.13
Book Value -- -- 87.48 -56.74 -45.17
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info -1,180.39-718.89---1,180.39--
Net Margin info -7,081.84-4,963.42-----7,081.84
Return on equity info -137.09-102.52-131.13-207.83-72.32
Return on Capital info -87.27-72.25-50.86-142.78-68.17
Return on Assets info -73.82-61.52-40.38-120.93-60.15
Debt to Equity (x) info ----0.085.220.07
ROCE

-50.86

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
-50.86
-142.78
-68.17
-62.27
-37.16
Peer Median
--
--
--
--
--
ROE

-131.13

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
-131.13
-207.83
-72.32
-64.16
-37.16
Peer Median
--
--
--
--
--
ROA

-40.38

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
-40.38
-120.93
-60.15
-55.44
-30.71
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
-1,180.39
--
--
-257.40
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
-1,180.39
-7,081.84
-2,845.01
-231.29
Peer Median
--
--
--
--
--
Revenue Growth

-1.00

--

Year on year growth in net sales

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
-1.00
--
--
-1.00
-0.14
Peer Median
--
--
--
--
--
EBIT Growth

65.55

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
65.55
-25.93
1.62
-62.17
-92.96
Peer Median
--
--
--
--
--
Net Profit Growth

83.61

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
83.61
-30.01
-2.52
-67.75
-84.98
Peer Median
--
--
--
--
--
EPS Growth

0.87

--

Year on year growth in earnings per share

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
0.87
-0.22
0.20
-0.17
-0.72
Peer Median
--
--
--
--
--
Debt to Equity

0.08

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
0.08
5.22
0.07
0.06
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.08

--

(Short term borrowings / Net worth)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
0.08
0.16
0.02
0.01
--
Peer Median
--
--
--
--
--
Current Ratio

3.60

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
3.60
4.39
6.45
8.14
9.42
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
--
6.53
8.17
9.56
Peer Median
--
--
--
--
--
Interest Coverage

-1.91

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
-1.91
-333.59
--
--
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
--
--
--
8.97
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
0.10
--
--
0.13
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
28.86
--
--
25.76
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
-392.50
-197.57
-5.93
-67.20
Peer Median
--
--
--
--
--
Payable days

577.81

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
577.81
718.78
395.13
7.90
6.40
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
--
-1,082.42
--
--
-47.84
Peer Median
--
--
--
--
--
Price / Earnings

-0.84

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
-0.84
-0.02
-0.20
-0.18
-0.15
Peer Median
--
--
--
--
--
Price / Book Value

0.78

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
0.78
0.30
0.17
0.11
0.06
Peer Median
--
--
--
--
--
EV/EBITDA

0.21

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Calithera Biosciences (CALA)
0.21
0.12
1.00
1.44
2.26
Peer Median
--
--
--
--
--
loading...
loading...